| Document |
Document Title |
|
JPS6081199A |
NEW MATERIAL:A compound of formula I [R1 is β-D-glucopyranosyl(1→6)-β-D- glucopyranosyl, α-L-arabinopyranosyl( 1→6 )-β-D-glucopyranosyl, α-L-arabinofuranosyl(1→6)-β-D-glucopyranosyl or β-D-glucopyranosyl]. EXAMPLE: 3-O-[ 6-O...
|
|
JPS6069096A |
Steroids of the formulaand a therapeutic composition containing same which are useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents.
|
|
JPS6054310A |
PURPOSE: To provide a cosmetic having excellent hair tonic effect and acne- remedying effect, and free from undesirable side effects such as hormonic activity, by using a specific 4-estren-3-one-17β-ethoxy derivative as an active compon...
|
|
JPS6038325A |
PURPOSE: To obtain a narcotic sedative agent by using a specific steroid saponin or its salt originated from starfish. CONSTITUTION: The narcotic and sedative agent containing the steroid saponin of formula I (R1 is group of formula II, ...
|
|
JPS6034990A |
17-haloethynyl steroids of the partial formula wherein R1 is hydrogen or methyl, R2 is alkyl of 1-4 carbon atoms, acyl of 1-7 carbon atoms, trimethylsilyl, 2-tetrahydropyranyl, or nitrate, X is bromine or iodine, and V is methylene, ethy...
|
|
JPS6028987A |
NEW MATERIAL:The compound of formula I (R is -COOH or -CONHCH2COOH). EXAMPLE: 3β,12β,14β-Trihydroxy-5β,17β-etianic acid-3-tridigitoxide. USE: Useful as a hapten of hapten antigen for the preparation of antibody for the immunochemica...
|
|
JPS59231022A |
PURPOSE: A hypotensor to be related to parasympathetic nerve mechanism, comprising a steroid saponin derived from Asteroidea, or its salt, including a novel compound, as an active ingredient. CONSTITUTION: A steroid saponin shown by the ...
|
|
JPS5943960B2 |
NEW MATERIAL:3-0-[ beta-D-Glucopyranosyl( 1 2 )-beta-D-galactopyranosyl-( 1 2)- beta-D-glucuronopyranosyl ]-21-0-[ alpha-D-glucopyranosyl( 1 3 )-alpha-L-arabinopyranosyl ]-soyasapogenol A or 3-0-[ beta-D-galactopyranosyl-( 1 2 )-beta-D-g...
|
|
JPS5942680B2 |
The invention is concerned with new chemical compounds being the hemiesters of steryl glycosides, methods of preparing these hemiesters, and pharmaceutically, particularly anti-inflammatory, compositions containing the new hemiesters.
|
|
JPS5940840B2 |
The present invention relates to a dienic derivative of the androstane series having the formula WHEREIN R is a member selected from the group consisting of hydrogen, alkyl having 1 to 4 carbon atoms and alkali metal, R' and R'' are memb...
|
|
JPS5933600B2 |
The invention relates to novel 11,11-alkylidene steroids of the estrane and (19-nor-)pregnane series having a double bond starting from carbon atom 5, the alkylidene group in 11-position having the formula R1 ANGLE C= , R2 wherein R1 and...
|
|
JPS5922719B2 |
|
|
JPS59500716A |
Chemiluminescent substituted epidioxy-polycycloalkyl polycycloalkanes of the formula in which A and B represent alkyiene radicals, which alkylene radicals may be attached to each other via an alkylene radical C, R1 represents chloro, bro...
|
|
JPS5967225A |
Methods for the production of steroids (sapogenins) and steroidal glycosides (saponins) from cell, root-cell and shoot tissue cultures of the Yucca plant. The cultures were established and maintained in a suitable nutrient plant cell med...
|
|
JPS5942399A |
1502513 Steroid[16α,17-b] dioxanes E R SQUIBB & SONS Inc 13 May 1975 [8 Nov 1974] 20206/75 Heading C2U The invention comprises #4 steroids of Formula I and their #1,4, #4,6 and #1,4,6 analogues wherein A 1 is selected from (the valency ...
|
|
JPS5942400A |
1502513 Steroid[16α,17-b] dioxanes E R SQUIBB & SONS Inc 13 May 1975 [8 Nov 1974] 20206/75 Heading C2U The invention comprises #4 steroids of Formula I and their #1,4, #4,6 and #1,4,6 analogues wherein A 1 is selected from (the valency ...
|
|
JPS591279B2 |
|
|
JPS58214856A |
There is described an enzyme immunoassay for measuring the concentration of an analyte in a sample wherein the substrate for the enzyme forms at least a part of the sample. In a particular embodiment the sample comprises or consists of a...
|
|
JPS5855154B2 |
|
|
JPS5850237B2 |
The synthesis of 25-hydroxycholesterol and 1 alpha ,25-dihydroxycholesterol in which the sterol nucleus of an ester of hyodeoxycholic acid is stabilized by protection of the 3 and 6 alpha -hydroxyl groups with alkyl groups, alkyl ether g...
|
|
JPS5850240B2 |
The present invention relates to a dienic derivative of the androstane series having the formula WHEREIN R is a member selected from the group consisting of hydrogen, alkyl having 1 to 4 carbon atoms and alkali metal, R' and R'' are memb...
|
|
JPS5848155B2 |
|
|
JPS58148854A |
Process for the preparation of 1 alpha ,25,26-trihydroxycholecalciferol in the form of the C-25 R or S epimer or in the form of a mixture thereof, starting with a compound of the formula in which R<1> represents lower alcohol, phenyl or ...
|
|
JPS58116499A |
NEW MATERIAL:A cyclic acetal derivative of sterylglucoside shown by the formulaI(R1 is β-sitosteryl, campesteryl, stigmasteryl, cholesteryl; R2 is lower alkyl or phenyl). EXAMPLE: Steryl-4,6-propylidene-β-D-glucopyranoside. USE: A vasc...
|
|
JPS58116500A |
NEW MATERIAL:A 2,3-oxidoalkylidene-4,6-alkylidene-β-D-glucopyranoside derivative shown by the formulaI(R is β-sitosteryl, campesteryl, stigmasteryl, or cholesteryl; R1 is H or methyl). EXAMPLE: Steryl-2,3-oxidoethylidene-4,6-ethylidene...
|
|
JPS5831358B2 |
|
|
JPS5831359B2 |
|
|
JPS58113200A |
New steroidal chiral phosphines of formula (I) wherein R represents a phosphorated group selected between methods for their preparation; catalytic systems comprising metal complexes and the above steroidal chiral phosphines; asymmetrical...
|
|
JPS5899417A |
PURPOSE: A remedy for poliosis useful for remedying poliosis, bearable in a long- term continuous use, having low toxicity, comprising an extract of Gynostemma pentaphyllum Makino as an active ingredient. CONSTITUTION: A remedy for polio...
|
|
JPS5880000A |
NEW MATERIAL:A compound of formulaI(R is H, lower alkanoyl, benzoyl, lower alkoxycarbonyl or two Rs together represent carbonyl and further a cyclic carbonic ester as a whole). EXAMPLE: 2R,3S-Diacetoxy-24S-methyl-22,23-oxido-5α-cholesta...
|
|
JPS5822479B2 |
Novel 1 alpha ,3 beta -dihydroxy-24-oxocholesta-5,7-diene and the hydroxyl group-protected derivatives thereof. Said novel 1 alpha -hydroxy-24-oxovitamin D3 and said novel intermediates are also useful as the intermediates of 1 alpha ,24...
|
|
JPS5821640B2 |
4-Androstene-3,17-dione and 1,4-androstadiene-3,17-dione are converted to 3-(17 beta -hydroxy-4-androsten-3-on-17 alpha -yl)-propionic acid lactone in three steps by reaction with propargyl alcohol in the presence of an alkali alcoholate...
|
|
JPS5821639B2 |
1,3-Dihydroxy-1,3,5(10)-8alpha-oestratrienes or their ethers or esters of the following formula in which the substituents are defined in Claim 1 are prepared. The said compounds are obtained by hydrogenating the 8(9) and, if present, the...
|
|
JPS5857398A |
NEW MATERIAL:The compound of formula {R1 is[β-glucopyranosyl (1→2)-]β- glucopyranosyl or[β-glucopyranosyl(1→2)-]α-arabinopyranosyl-H; R2 is CH2OH or CHO; R3 is[β-xylopyranosyl(1→6)-β-]glucopyranosyl or OH; R4 is β-glucopyran...
|
|
JPS5855496A |
PURPOSE: To separate only a water-soluble component containing saponin as a film permeated solution simply and inexpensively, by substituting a methanol extracted solution of soybean with an aqueous system, making a water- insoluble comp...
|
|
JPS5852268A |
1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A cholecalciferol derivative of the formula see diagramm : EP0073465,P14,F3 1. Claims for the contracting state : AT A process for the manufacture of a choleca...
|
|
JPS589119B2 |
|
|
JPS5826898A |
This invention relates to novel isomers of naturally occurring cardiotonic compounds, specifically novel isobufalins and novel isoresibufogenins. This invention also relates to a novel method of preparing the novel isomers.
|
|
JPS58999A |
NEW MATERIAL:A clathrate of proscillaridin with cyclodextrin. USE: A water-soluble and high-stability carbiotonic of proscillaridin. PREPARATION: For example, proscillaridine of the formula and a cyclodextrin such as γ-cyclodextrin are ...
|
|
JPS5758357B2 |
|
|
JPS57183783A |
The invention is concerned with a process for the preparation of 1 hydrogen or hydroxy cholesterol derivatives and intermediates therefor. The compounds of the present invention are useful as intermediates in the preparation of 24,25-dih...
|
|
JPS5751840B2 |
The synthesis of 25-hydroxycholesterol and 25-hydroxycholecalciferol from animal bile starting materials in which hyodeoxycholic acid or an ester thereof is converted to the 3 beta -hydroxy-5-cholenic acid alkyl ester, and this is conver...
|
|
JPS5751383B2 |
Novel 1 alpha -hydroxy-24-dehydrovitamin D3 and its hydroxyl-protected derivatives; novel 1 alpha -hydroxy-24-dehydroprevitamin D3 and its hydroxyl-protected derivatives; and novel 1 alpha ,3 beta -dihydroxycholesta-5,7,24-triene or its ...
|
|
JPS57145899A |
NEW MATERIAL:A compound shown by the formula. USE: A drug having hypotensive action, etc. PROCESS: Astropectea latespinesus Meissner belonging to Asteroidea of Echinodermata is soaked in water and extracted to give a water extract, which...
|
|
JPS5742640B2 |
|
|
JPS5741480B1 |
1374079 Proscillaridin esters BOEHRINGER INGELHEIM GmbH 22 Dec 1971 [23 Dec 1970] 59726/71 Heading C2U The invention comprises compounds of formula wherein R 1 is the group R 2 is C 1-4 haloalkyl, (cycloalkyl)-C 1-4 alkyl, C 2-4 alkyl, C...
|
|
JPS57128632A |
PURPOSE: To obtain a stable addition product, having almost no hygroscopicity, capable of being stored for a long time, having hypotensive action, etc., by adding mannitol to a saponin compound contained in a medicinal ginseng. CONSTITUT...
|
|
JPS57116017A |
PURPOSE: To provide an orally administrable antithrombogenetic or anticoagulative agent containing ginseng saponin as an active component, useful for the prevention and remedy of thrombotic cerebromalacia, thrombocytopenic purpura, etc.,...
|
|
JPS5725560B2 |
1409239 3α-Hydroxy-steroids GLAXO LABORATORIES Ltd 8 Nov 1972 [11 Nov 1971] 52465/71 Heading C2U 3α-Hydroxy-5α-steroids, including the novel 3α - hydroxy - 19 - nor - 5α - pregnan - 20 - one, are prepared by reducing 3-oxo-5α-stero...
|
|
JPS5724800B2 |
|
